These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 23177202)
21. Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering. Lešnik U; Lukežič T; Podgoršek A; Horvat J; Polak T; Šala M; Jenko B; Harmrolfs K; Ocampo-Sosa A; Martínez-Martínez L; Herron PR; Fujs Š; Kosec G; Hunter IS; Müller R; Petković H Angew Chem Int Ed Engl; 2015 Mar; 54(13):3937-40. PubMed ID: 25650563 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and antimicrobial evaluation of amino sugar-based naphthoquinones and isoquinoline-5,8-diones and their halogenated compounds. Dias FRF; Novais JS; Devillart TADNS; da Silva WA; Ferreira MO; Loureiro RS; Campos VR; Ferreira VF; de Souza MCBV; Castro HC; Cunha AC Eur J Med Chem; 2018 Aug; 156():1-12. PubMed ID: 30006155 [TBL] [Abstract][Full Text] [Related]
25. Utilization of Vibrio cholerae as a Model Organism to Screen Natural Product Libraries for Identification of New Antibiotics. Sikora AE; Tehan R; McPhail K Methods Mol Biol; 2018; 1839():135-146. PubMed ID: 30047060 [TBL] [Abstract][Full Text] [Related]
26. Antibiotic concentration and antibiotic-resistant bacteria in two shallow urban lakes after stormwater event. Zhang S; Pang S; Wang P; Wang C; Han N; Liu B; Han B; Li Y; Anim-Larbi K Environ Sci Pollut Res Int; 2016 May; 23(10):9984-92. PubMed ID: 26865482 [TBL] [Abstract][Full Text] [Related]
27. Isolation of the antibiotic pseudopyronine B and SAR evaluation of C3/C6 alkyl analogs. Bouthillette LM; Darcey CA; Handy TE; Seaton SC; Wolfe AL Bioorg Med Chem Lett; 2017 Jun; 27(12):2762-2765. PubMed ID: 28478925 [TBL] [Abstract][Full Text] [Related]
28. A Trojan-Horse Strategy Including a Bacterial Suicide Action for the Efficient Use of a Specific Gram-Positive Antibiotic on Gram-Negative Bacteria. Schalk IJ J Med Chem; 2018 May; 61(9):3842-3844. PubMed ID: 29683323 [TBL] [Abstract][Full Text] [Related]
29. Screening for new antifolates of microbial origin and a new antifolate AM-8402. Omura S; Murata M; Kimura K; Matsukura S; Nishihara T; Tanaka H J Antibiot (Tokyo); 1985 Aug; 38(8):1016-24. PubMed ID: 4044404 [TBL] [Abstract][Full Text] [Related]
30. Screening for non-polyenic antifungal antibiotics produced by rare Actinomycetales. Hacène H; Sabaou N; Bounaga N; Lefebvre G Microbios; 1994; 79(319):81-5. PubMed ID: 7968663 [TBL] [Abstract][Full Text] [Related]
31. Using Chemoinformatics, Bioinformatics, and Bioassay to Predict and Explain the Antibacterial Activity of Nonantibiotic Food and Drug Administration Drugs. Kahlous NA; Bawarish MAM; Sarhan MA; Küpper M; Hasaba A; Rajab M Assay Drug Dev Technol; 2017 Apr; 15(3):89-105. PubMed ID: 28346800 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. Farrell DJ; Robbins M; Rhys-Williams W; Love WG Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634 [TBL] [Abstract][Full Text] [Related]
35. Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria. Muñoz KA; Hergenrother PJ Acc Chem Res; 2021 Mar; 54(6):1322-1333. PubMed ID: 33635073 [TBL] [Abstract][Full Text] [Related]
36. A lux-based Staphylococcus aureus bioluminescence screening assay for the detection/identification of antibiotics and prediction of antibiotic mechanisms. Yang Z; Cui Q; Zhang M; Li Z; Wang M; Xu H J Antibiot (Tokyo); 2020 Dec; 73(12):828-836. PubMed ID: 32678336 [TBL] [Abstract][Full Text] [Related]
37. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents. Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294 [TBL] [Abstract][Full Text] [Related]
38. Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria. Matsui K; Kan Y; Kikuchi J; Matsushima K; Takemura M; Maki H; Kozono I; Ueda T; Minagawa K J Med Chem; 2020 Jun; 63(11):6090-6095. PubMed ID: 32378891 [TBL] [Abstract][Full Text] [Related]
39. Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights. Masschelein J; Jenner M; Challis GL Nat Prod Rep; 2017 Jul; 34(7):712-783. PubMed ID: 28650032 [TBL] [Abstract][Full Text] [Related]
40. Novel approach to combat antibiotic resistance: evaluation of some Armenian herb crude extracts for their antibiotic modulatory and antiviral properties. Ginovyan M; Trchounian A J Appl Microbiol; 2019 Aug; 127(2):472-480. PubMed ID: 31136046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]